VRTX NASDAQ
Vertex Pharmaceuticals Incorporated
1W: -3.8%
1M: -0.9%
3M: -9.1%
YTD: -4.1%
1Y: -3.0%
3Y: +25.6%
5Y: +99.7%
$434.52
+0.98 (+0.23%)
Weekly Expected Move ±3.1%
$410
$423
$437
$450
$463
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
Most healthcare companies report higher Y/Y EPS in strong earnings week
VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Michel Lagarde At Vertex Pharmaceuticals Acquires Stock Options Worth $9K
BRUCE SACHS Backs Up Beliefs With A Notable Acquisition Of Vertex Pharmaceuticals Stock Options Worth $9K
Is This Millionaire-Maker Biotech Stock a Buy Right Now?
These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q1 Earnings
VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales Growth
Vertex Pharmaceuticals Posts Mixed Q1; Investors Focus On Non-CF Pipeline For Growth
CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates
Vertex projects 2026 revenue of $12.95B-$13.1B while targeting $500M-plus from non-CF products
Vertex (VRTX) Reports Q1 Earnings: What Key Metrics Have to Say
Vertex (VRTX) Q1 2026 Earnings Call Transcript
Vertex Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates
Vertex Pharmaceuticals Reports Mixed Q1 Results
Vertex (VRTX) Q2 2025 Earnings Call Transcript
Here are the major earnings after the close Monday
Breakfast News: Abel Takes Berkshire Center Stage
Earnings Scheduled For May 4, 2026
S&P 500 Settles At New High As Apple Shares Gain: Fear Index Remains In 'Greed' Zone
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
Tyson Foods, Williams Companies And 3 Stocks To Watch Heading Into Monday
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?
Set It and Forget It: 3 Monster Stocks Worth Holding Through Whatever Comes Next
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
3 Growth Stocks That Could Generate 10X Returns
Vertex Gears Up to Report Q1 Earnings: What Investors Can Expect
Analysts Estimate Myriad Genetics (MYGN) to Report a Decline in Earnings: What to Look Out for
Concurrent Investment Advisors LLC Raises Stake in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CRISPR Therapeutics to Report Q1 Earnings: Is a Beat in the Cards?
Calamos Advisors LLC Sells 1,784 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
Cwm LLC Grows Stock Position in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Arizona State Retirement System
3 Healthcare Stocks With the Most Durable Competitive Moats
B. Metzler seel. Sohn & Co. AG Buys 199,847 Shares of Vertex Pharmaceuticals Incorporated $VRTX
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Merit Financial Group LLC Buys 2,880 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Davidson Investment Advisors Grows Holdings in Vertex Pharmaceuticals Incorporated $VRTX
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term
Vertex Pharmaceuticals Incorporated $VRTX Stock Position Lifted by Asset Management One Co. Ltd.
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade
Is Vertex Pharmaceuticals' Empire in Trouble?
Choreo LLC Grows Position in Vertex Pharmaceuticals Incorporated $VRTX
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.
Burney Co. Decreases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Andrew Hill Investment Advisors Inc.
4,828 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Fiduciary Alliance LLC
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
BIP Wealth LLC Takes $551,000 Position in Vertex Pharmaceuticals Incorporated $VRTX
Nasdaq, S&P 500, Dow futures slip as hopes of U.S.-Iran resolution fade
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex Pharma in pact with Halozyme for Hypercon drug delivery tech
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?
Vertex Pharmaceuticals Incorporated $VRTX Position Boosted by Country Trust Bank
Perpetual Ltd Buys New Shares in Vertex Pharmaceuticals Incorporated $VRTX
Aberdeen Group plc Has $118.81 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
F&V Capital Management LLC Buys Shares of 3,645 Vertex Pharmaceuticals Incorporated $VRTX
F&V Capital Management LLC Buys Shares of 3,645 Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Banque Pictet & Cie SA
Allspring Global Investments Holdings LLC Cuts Stock Position in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharma wins FDA label expansion for cystic fibrosis therapies
Vertex completes rolling BLA submission for povetacicept
Boston Common Asset Management LLC Sells 20,952 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Exchange Traded Concepts LLC Boosts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
If You Invested $1000 In Vertex Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
Beacon Investment Advisory Services Inc. Sells 2,049 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway
2 Stocks I Plan to Hold for the Next 20 Years
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Congress Asset Management Co.
Baker Chad R Sells 8,990 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Czech National Bank Buys 1,784 Shares of Vertex Pharmaceuticals Incorporated $VRTX
CCM Investment Advisers LLC Decreases Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals (VRTX) Laps the Stock Market: Here's Why
Where Will Vertex Pharmaceuticals Be in 1 Year?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Assenagon Asset Management S.A. Has $377.58 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
Citi's large-cap stocks with negative ROE trends
Gradient Investments LLC Has $19.76 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Nordea Investment Management AB Has $202.61 Million Position in Vertex Pharmaceuticals Incorporated $VRTX
Grove Bank & Trust Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Park Avenue Securities LLC
Cooper Financial Group Acquires 3,021 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Is CRISPR Therapeutics Stock a Buy Now?
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?